Transgene S.A.

France


 
Quantité totale PI 125
Rang # Quantité totale PI 10 562
Note d'activité PI 2,3/5.0    26
Rang # Activité PI 30 739
Symbole boursier
ISIN FR0005175080
Capitalisation 94.5M  (EUR)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

37 5
22 0
58 3
0
 
Dernier brevet 2024 - Novel combinations of antibodies...
Premier brevet 1983 - Expression vectors of catechol 2...
Dernière marque 2024 - TRANSGENE
Première marque 2013 - TRANSGENE

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for the treatment of cancer, central nervous system diseases, and hem...
2023 Invention Chimeric poxviruses
Invention Fusion protein comprising a surfactant-protein-d and a member of the tnfsf
Invention Recombinant virus expressing interleukin-12
Invention Personalized vaccine. The present invention generally relates to a personalized cancer vaccine c...
2022 Invention Immunotherapeutic vaccine and antibody combination therapy. The present invention relates to a c...
Invention Novel combinations of antibodies and uses thereof. The present invention generally relates to a ...
Invention Novel combinations of antibodies and uses thereof. The present invention generally relates to a c...
Invention The polarity and specificity of sars-cov2 -specific t lymphocyte responses as a biomarker of dise...
2021 Invention Treatment of immune depression. The present invention is in the field of immunotherapy. The inve...
Invention Treatment of immune depression. The present invention is in the field of immunotherapy. The inven...
2020 Invention Process for designing a recombinant poxvirus for a therapeutic vaccine. The present invention ge...
Invention Process for designing a recombinant poxvirus for a therapeutic vaccine. The present invention gen...
Invention Combination of a poxvirus encoding hpv polypeptides with an anti-pd-l1 antibody. The present inv...
Invention Combination of a poxvirus encoding hpv polypeptides and il-2 with an anti-pd-l1 antibody. The pre...
Invention Combination of oncolytic virus with immune checkpoint modulators. The present invention provides...
P/S Downloadable bioinformatics software for tracking and analyzing cancer diagnoses; downloadable ar...
2019 Invention M2-defective poxvirus. The present invention is in the field of oncolytic viruses. The invention...
Invention M2-defective poxvirus. The present invention is in the field of oncolytic viruses. The invention ...
Invention Immunosuppressive m2 protein. The invention is in the field of immunity and provides a poxviral p...
Invention Oncolytic virus for expression of immune checkpoint modulators. The present invention provides an...
Invention Production of viral vaccines on an avian cell line. The present invention relates to the use of ...
Invention Production of viral vaccines on an avian cell line. The invention relates to the use of the immor...
Invention Anti-ctla-4 antibodies and their use in depleting ctla-4-positive cells. Described are novel anti...
Invention Novel antibodies and nucleotide sequences, and uses thereof. Described are novel anti-CTLA-4 anti...
Invention Parapoxvirus vectors. The present invention is in the field of viral immunotherapy. The inventio...
Invention Parapoxvirus vectors. The present invention is in the field of viral immunotherapy. The invention...
Invention Methods for treating or preventing hbv infection or hbv related diseases. The present invention r...
2018 Invention Composition for treating hbv infection. The present invention provides a composition comprising h...
Invention Oncolytic viruses expressing agents targeting metabolic immune modulators. The present invention ...
Invention Personalized vaccine. The present invention generally relates to a personalized cancer vaccine co...
Invention Personalized vaccine comprising a recombinant poxvirus expressing a fusioin of nepopeptides. The ...
2017 Invention Oncolytic viruses and therapeutic molecules. The present invention relates to an oncolytic virus...
Invention Oncolytic viruses and therapeutic molecules. The present invention relates to an oncolytic virus ...
Invention Cowpox-based oncolytic vectors. The present invention relates to a cowpox virus comprising at lea...
P/S Therapeutic vaccines in oncology; immunotherapy products in oncology; preparation of therapeutic...
P/S Therapeutic vaccines in oncology; immunotherapy products, namely, pharmaceutical products for the...
P/S Therapeutic vaccines in oncology; customized immunotherapy products; therapeutic vaccine prepara...
P/S Therapeutic vaccines in oncology; customized immunotherapy products, namely, pharmaceutical prepa...
Invention Immunotherapeutic product and mdsc modulator combination therapy. The present invention provides...
Invention Immunotherapeutic product and mdsc modulator combination therapy. The present invention provides ...
Invention Combination therapy with cpg tlr9 ligand. The present invention generally relates to an immunost...
Invention Combination therapy with cpg tlr9 ligand. The present invention generally relates to an immunosti...
2016 Invention Hbv polymerase mutants. The present invention relates to polymerase HBV mutant polypeptides compr...
Invention Composition for treating hbv infection. The present invention provides a composition comprising ...
P/S Pharmaceutical products for cancer treatment; pharmaceutical products for lung cancer treatment;...
Invention Combination product with autophagy modulator. The present invention relates to a combination prod...
Invention Immunotherapeutic vaccine and antibody combination therapy. The present invention relates to a co...
2015 Invention Stable liquid vaccinia virus formulations. The present invention relates to liquid formulations o...
Invention Combination of oncolytic virus with immune checkpoint modulators. The present invention provides ...
Invention Fusion of heterooligomeric mycobacterial antigens. Mycobacterium infection.
2013 P/S Research and scientific studies in the fields of chemistry, [ bacteriology, ] genetics, human [ a...